Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Case Report: Obliterative Bronchiolitis in Rheumatoid Arthritis

Robin Paudel, MD, Prerna Dogra, MD, & Richard S. Morehead, MD  |  Issue: January 2020  |  

Prerna Dogra, MDPrerna Dogra, MD, obtained her medical degree from Topiwala National Medical College, India. Her internal medicine residency was at Jersey City Medical Center. She is currently an assistant professor of medicine at the University of Kentucky.

Richard Scott Morehead, MDRichard Scott Morehead, MD, is a professor of pulmonary and critical care medicine at the University of Kentucky. He received his medical degree from Oral Roberts University School of Medicine. He performed his residency at Emory University before completing his fellowship in pulmonary and critical care at the University of Alabama Medical Center.

ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Silman A, Pearson J. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 2002;4 Suppl 3:S265–S272.
  2. Sihvonen S, Korpela M, Laippala P, et al. Death rates and causes of death in patients with rheumatoid arthritis: A population-based study. Scand J Rheumatol. 2004;33(4):221–227.
  3. Gonzalez A, Icen M, Kremers HM, et al. Mortality trends in rheumatoid arthritis: The role of rheumatoid factor. J Rheumatol. 2008 Jun;35(6):1009–1014.
  4. Barker AF, Bergeron A, Rom WN, Hertz MI. Obliterative bronchiolitis. N Engl J Med. 2014 May 8;370(19):1820–1828.
  5. Geddes DM, Corrin B, Brewerton DA, et al. Progressive airway obliteration in adults and its association with rheumatoid disease. Q J Med. 1977 Oct;46(184):427–444.
  6. Lin E, Limper AH, Moua T. Obliterative bronchiolitis associated with rheumatoid arthritis: Analysis of a single-center case series. BMC Pulm Med. 2018 Jun 22;18(1):105.
  7. Devouassoux G, Cottin V, Liote H, et al. Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis. Eur Respir J. 2009 May;33(5):1053–1061.
  8. Sweatman MC, Markwick JR, Charles PJ, et al. Histocompatibility antigens in adult obliterative bronchiolitis with or without rheumatoid arthritis. Dis Markers. 1986 Jun;4(1–2):19–26.
  9. Wilkes DS. Autoantibody formation in human and rat studies of chronic rejection and primary graft dysfunction. Semin Immunol. 2012 Apr;24(2)131–135.
  10. Hachem RR, Tiriveedhi V, Patterson GA, et al. Antibodies to K-α 1 tubulin and collagen v are associated with chronic rejection after lung transplantation. Am J Transplant. 2012 Aug;12(8):2164–2171.
  11. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant. 2002 Mar;21(3):297–310.
  12. Tanaka N, Kim JS, Newell JD, et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology. 2004 Jul;232(1):81–91.
  13. Watanabe S, Ishiyama K, Saeki K, et al. Tamibarotene for the treatment of bronchiolitis obliterans associated with chronic graft-vs-host disease. Chest. 2019 Jan;155(1):e1–e4.
  14. Vos R, Eynde RV, Ruttens D, et al. Montelukast in chronic lung allograft dysfunction after lung transplantation. J Heart Lung Transplant. 2019 May;38(5)516–527.
  15. Yadav H, Peters SG, Keogh KA, et al. Azithromycin for the treatment of obliterative bronchiolitis after hematopoietic stem cell transplantation: A systematic review and meta-analysis. Biol Blood Marrow Transplant. 2016 Dec;22(12):2264–2269.
  16. 16. Hachem R, Corris P. Extracorporeal photopheresis for bronchiolitis obliterans syndrome after lung transplantation. Transplantation. 2018 Jul;102(7):1059–1065.
  17. Ruttens D, Verleden SE, Vandermeulen E, et al. Prophylactic azithromycin therapy after lung transplantation: Post hoc analysis of a randomized controlled trial. Am J Transplant. 2016 Jan;16(1):254–261.
  18. Hayakawa H, Sato A, Imokawa S, et al. Bronchiolar disease in rheumatoid arthritis. Am J Respir Crit Care Med. 1996 Nov;154(5):1531–1536.
  19. Yam LY, Wong R. Bronchiolitis obliterans and rheumatoid arthritis. Report of a case in a Chinese patient on d-penicillamine and review of the literature. Ann Acad Med Singapore. 1993 May;22(3):365–368.
  20. Penny WJ, Knight RK, Rees AM, et al. Obliterative bronchiolitis in rheumatoid arthritis. Ann Rheum Dis. 1982 Oct;41(5):469–472.
  21. Cortot AB, Cottin V, Miossec P, et al. Improvement of refractory rheumatoid arthritis-associated constrictive bronchiolitis with etanercept. Respir Med. 2005 Apr;99(4):511–514.
  22. Abhishek A, Gaywood I, Hubbard R. Case Reports (II) (546–574). Obliterative bronchiolitis complicating rheumatoid arthritis (RA) treated with etanercept. Rheumatology. 2008 Apr;47(suppl 2):ii158–ii165.
  23. van de Laar MAFJ, Westermann CJJ, Wagenaar SS, Dinant HJ. Beneficial effect of intravenous cyclophosphamide and oral prednisone on D‐penicillamine‐associated bronchiolitis obliterans. Arthritis Rheum. 1985 Jan;28(1):93–97.

Related Articles
    HSCT for Severe Autoimmune Diseases

    HSCT for Severe Autoimmune Diseases

    Despite the innovations of new biologics and disease-modifying anti-rheumatic drugs, a large unmet need remains for patients with rheumatic autoimmune disease. Treatment remains limited for many conditions, including for conditions with a dim prognosis, such as systemic sclerosis.1 One promising treatment avenue is hematopoietic stem-cell transplantation (HSCT). Here, we provide background on HSCT for severe…

    Ethics Forum: What to Do When an Autoimmune Patient Needs a Transplant?

    Despite our best efforts and modern interventions, we still have patients in the intensive care unit with organ failure. Although renal failure can be mitigated by dialysis, patients with cardiac or respiratory failure secondary to active autoimmune disease raise difficult clinical and ethical issues. Two recent cases, both with organ failure, led us to examine…